The melanin-concentrating hormone (MCH) system modulates behaviors associated with psychiatric disorders

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Chung, Shinjae ^a   Verheij, Michel M M ^b   Hesseling, Peter ^b   van Vugt, Ruben W M ^b   Buell, Mahalah ^c   Belluzzi, James D ^a   Geyer, Mark A ^c   Martens, Gerard J M ^b   Civelli, Olivier ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; DIZOCILPINE; GLUTAMIC ACID; MELANIN CONCENTRATING HORMONE; DIZOCILPINE MALEATE; HYPOPHYSIS HORMONE; HYPOTHALAMUS HORMONE; MELANIN; MELANIN-CONCENTRATING HORMONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; GENE EXPRESSION; LATERAL HYPOTHALAMUS; MALE; MENTAL DISEASE; MESOCORTICOLIMBIC DOPAMINE PATHWAY; MESOLIMBIC DOPAMINERGIC SYSTEM; MOUSE; NEUROMODULATION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PREPULSE INHIBITION; RAT; SCHIZOPHRENIA; SENSORY GATING; STARTLE REFLEX; STEREOTYPY; ANIMAL; ANIMAL BEHAVIOR; C57BL MOUSE; DRUG EFFECT; INJECTION; NERVE CELL INHIBITION; PATHOPHYSIOLOGY;

MUS; RATTUS;

ANIMALS; APOMORPHINE; BEHAVIOR, ANIMAL; DIZOCILPINE MALEATE; HYPOTHALAMIC HORMONES; INJECTIONS; MALE; MELANINS; MENTAL DISORDERS; MICE; MICE, INBRED C57BL; NEURAL INHIBITION; PITUITARY HORMONES; RATS; STARTLE REACTION; STEREOTYPED BEHAVIOR;

EID: 79960461191     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019286     Document Type: Article

References (57)

1. Braff DL, Geyer MA, Swerdlow NR, (2001) Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 156: 234-258.
2. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR, (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) 156: 117-154.
3. Swerdlow NR, Geyer MA, Braff DL, (2001) Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl) 156: 194-215.
4. Braff DL, Geyer MA, (1990) Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry 47: 181-188.
5. Braff D, Stone C, Callaway E, Geyer M, Glick I, et al. (1978) Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 15: 339-343.
6. Braff DL, Grillon C, Geyer MA, (1992) Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry 49: 206-215.
7. McGhie A, Chapman J, (1961) Disorders of attention and perception in early schizophrenia. Br J Med Psychol 34: 103-116.
8. Swerdlow NR, Caine SB, Geyer MA, (1992) Regionally selective effects of intracerebral dopamine infusion on sensorimotor gating of the startle reflex in rats. Psychopharmacology (Berl) 108: 189-195.
9. Swerdlow NR, Braff DL, Masten VL, Geyer MA, (1990) Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens. Psychopharmacology (Berl) 101: 414-420.
10. Swerdlow NR, Braff DL, Taaid N, Geyer MA, (1994) Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry 51: 139-154.
11. Swerdlow NR, Geyer MA, (1998) Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull 24: 285-301.
12. Keith VA, Mansbach RS, Geyer MA, (1991) Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle. Biol Psychiatry 30: 557-566.
13. Bakshi VP, Swerdlow NR, Geyer MA, (1994) Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther 271: 787-794.
14. Ellenbroek BA, Geyer MA, Cools AR, (1995) The behavior of APO-SUS rats in animal models with construct validity for schizophrenia. J Neurosci 15: 7604-7611.
15. van der Elst MC, Verheij MM, Roubos EW, Ellenbroek BA, Veening JG, et al. (2005) A single exposure to novelty differentially affects the accumbal dopaminergic system of apomorphine-susceptible and apomorphine-unsusceptible rats. Life Sci 76: 1391-1406.
16. van der Elst MC, Roubos EW, Ellenbroek BA, Veening JG, Cools AR, (2005) Apomorphine-susceptible rats and apomorphine-unsusceptible rats differ in the tyrosine hydroxylase-immunoreactive network in the nucleus accumbens core and shell. Exp Brain Res 160: 418-423.
17. Ellenbroek BA, Cools AR, (2002) Apomorphine susceptibility and animal models for psychopathology: genes and environment. Behav Genet 32: 349-361.
18. Ridley RM, (1994) The psychology of perserverative and stereotyped behaviour. Prog Neurobiol 44: 221-231.
19. Mahone EM, Bridges D, Prahme C, Singer HS, (2004) Repetitive arm and hand movements (complex motor stereotypies) in children. J Pediatr 145: 391-395.
20. Fasano A, Barra A, Nicosia P, Rinaldi F, Bria P, et al. (2008) Cocaine addiction: from habits to stereotypical-repetitive behaviors and punding. Drug Alcohol Depend 96: 178-182.
21. Rylander G, (1972) Psychoses and the punding and choreiform syndromes in addiction to central stimulant drugs. Psychiatr Neurol Neurochir 75: 203-212.
22. Schiorring E, (1981) Psychopathology induced by "speed drugs". Pharmacol Biochem Behav 14 (Suppl 1): 109-122.
23. Evans AH, Katzenschlager R, Paviour D, O'Sullivan JD, Appel S, et al. (2004) Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Mov Disord 19: 397-405.
24. Black KJ, Friedman JH, (2006) Repetitive and impulsive behaviors in treated Parkinson disease. Neurology 67: 1118-1119.
25. Randrup A, Munkvad I, (1967) Stereotyped activities produced by amphetamine in several animal species and man. Psychopharmacologia 11: 300-310.
26. Fog R, Pakkenberg H, (1971) Behavioral effects of dopamine and p-hydroxyamphetamine injected into corpus striatum of rats. Exp Neurol 31: 75-86.
27. Fog R, Randrup A, Pakkenberg H, (1970) Lesions in corpus striatum and cortex of rat brains and the effect on pharmacologically induced stereotyped, aggressive and cataleptic behaviour. Psychopharmacologia 18: 346-356.
28. Qu D, Ludwig DS, Gammeltoft S, Piper M, Pelleymounter MA, et al. (1996) A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 380: 243-247.
29. Kawauchi H, Kawazoe I, Tsubokawa M, Kishida M, Baker BI, (1983) Characterization of melanin-concentrating hormone in chum salmon pituitaries. Nature 305: 321-323.
30. Shimomura Y, Mori M, Sugo T, Ishibashi Y, Abe M, et al. (1999) Isolation and identification of melanin-concentrating hormone as the endogenous ligand of the SLC-1 receptor. Biochem Biophys Res Commun 261: 622-626.
31. Saito Y, Nothacker HP, Wang Z, Lin SH, Leslie F, et al. (1999) Molecular characterization of the melanin-concentrating-hormone receptor. Nature 400: 265-269.
32. Bachner D, Kreienkamp H, Weise C, Buck F, Richter D, (1999) Identification of melanin concentrating hormone (MCH) as the natural ligand for the orphan somatostatin-like receptor 1 (SLC-1). FEBS Lett 457: 522-524.
33. Chambers J, Ames RS, Bergsma D, Muir A, Fitzgerald LR, et al. (1999) Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1. Nature 400: 261-265.
34. Lembo PM, Grazzini E, Cao J, Hubatsch DA, Pelletier M, et al. (1999) The receptor for the orexigenic peptide melanin-concentrating hormone is a G-protein-coupled receptor. Nat Cell Biol 1: 267-271.
35. Severinsen JE, Als TD, Binderup H, Kruse TA, Wang AG, et al. (2006) Association analyses suggest GPR24 as a shared susceptibility gene for bipolar affective disorder and schizophrenia. Am J Med Genet B Neuropsychiatr Genet 141B: 524-533.
36. Saito Y, Cheng M, Leslie FM, Civelli O, (2001) Expression of the melanin-concentrating hormone (MCH) receptor mRNA in the rat brain. J Comp Neurol 435: 26-40.
37. Chung S, Hopf FW, Nagasaki H, Li CY, Belluzzi JD, et al. (2009) The melanin-concentrating hormone system modulates cocaine reward. Proc Natl Acad Sci U S A 106: 6772-6777.
38. Georgescu D, Sears RM, Hommel JD, Barrot M, Bolanos CA, et al. (2005) The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance. J Neurosci 25: 2933-2940.
39. Sears RM, Liu RJ, Narayanan NS, Sharf R, Yeckel MF, et al. (2010) Regulation of nucleus accumbens activity by the hypothalamic neuropeptide melanin-concentrating hormone. J Neurosci 30: 8263-8273.
40. Smith DG, Tzavara ET, Shaw J, Luecke S, Wade M, et al. (2005) Mesolimbic dopamine super-sensitivity in melanin-concentrating hormone-1 receptor-deficient mice. J Neurosci 25: 914-922.
41. Tyhon A, Lakaye B, Grisar T, Tirelli E, (2008) Deletion of Melanin-Concentrating Hormone Receptor-1 gene accentuates D-amphetamine-induced psychomotor activation but neither the subsequent development of sensitization nor the expression of conditioned activity in mice. Pharmacol Biochem Behav 88: 446-455.
42. Cools AR, Brachten R, Heeren D, Willemen A, Ellenbroek B, (1990) Search after neurobiological profile of individual-specific features of Wistar rats. Brain Res Bull 24: 49-69.
43. Ellenbroek BA, Cools AR, (2000) The long-term effects of maternal deprivation depend on the genetic background. Neuropsychopharmacology 23: 99-106.
44. Ralph-Williams RJ, Lehmann-Masten V, Otero-Corchon V, Low MJ, Geyer MA, (2002) Differential effects of direct and indirect dopamine agonists on prepulse inhibition: a study in D1 and D2 receptor knock-out mice. J Neurosci 22: 9604-9611.
45. Nagasaki H, Chung S, Dooley CT, Wang Z, Li C, et al. (2009) The pharmacological properties of a novel MCH1 receptor antagonist isolated from combinatorial libraries. Eur J Pharmacol 602: 194-202.
46. Brakkee JH, Wiegant VM, Gispen WH, (1979) A simple technique for rapid implantation of a permanent cannula into the rat brain ventricular system. Lab Anim Sci 29: 78-81.
47. Bittencourt JC, Presse F, Arias C, Peto C, Vaughan J, et al. (1992) The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization. J Comp Neurol 319: 218-245.
48. LaHoste GJ, Marshall JF, (1992) Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density. Synapse 12: 14-26.
49. Ljungberg T, Ungerstedt U, (1978) A method for simultaneous recording of eight behavioral parameters related to monoamine neurotransmission. Pharmacol Biochem Behav 8: 483-489.
50. Geyer MA, McIlwain KL, Paylor R, (2002) Mouse genetic models for prepulse inhibition: an early review. Mol Psychiatry 7: 1039-1053.
51. Borowsky B, Durkin MM, Ogozalek K, Marzabadi MR, DeLeon J, et al. (2002) Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist. Nat Med 8: 825-830.
52. Smith DG, Davis RJ, Rorick-Kehn L, Morin M, Witkin JM, et al. (2006) Melanin-concentrating hormone-1 receptor modulates neuroendocrine, behavioral, and corticolimbic neurochemical stress responses in mice. Neuropsychopharmacology 31: 1135-1145.
53. David DJ, Klemenhagen KC, Holick KA, Saxe MD, Mendez I, et al. (2007) Efficacy of the MCHR1 antagonist N-[3-(1-{[4-(3,4-difluorophenoxy)phenyl]methyl}(4-piperidyl))-4-methylphen yl]-2-methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocampal neurogenesis. J Pharmacol Exp Ther 321: 237-248.
54. Olianas MC, Onali P, (1988) Corticotropin-releasing factor activates tyrosine hydroxylase in rat and mouse striatal homogenates. Eur J Pharmacol 150: 389-392.
55. Arndt SS, Lohavech D, van't Klooster J, Ohl F, (2010) Co-species housing in mice and rats: effects on physiological and behavioral stress responsivity. Hormones and behavior 57: 342-351.
56. Croizier S, Franchi-Bernard G, Colard C, Poncet F, La Roche A, et al. (2011) A comparative analysis shows morphofunctional differences between the rat and mouse melanin-concentrating hormone systems. PLoSONE 5: e15471.
57. Tyhon A, Lakaye B, Adamantidis A, Tirelli E, (2008) Amphetamine- and cocaine-induced conditioned place preference and concomitant psychomotor sensitization in mice with genetically inactivated melanin-concentrating hormone MCH(1) receptor. Eur J Pharmacol 599: 72-80.